US Stock MarketDetailed Quotes

Boston Scientific (BSX)

Watchlist
  • 64.230
  • +0.810+1.28%
Close Apr 17 15:59 ET
  • 64.230
  • 0.0000.00%
Post 16:15 ET
95.46BMarket Cap33.11P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Boston Scientific (BSX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
19.87%20.07B
15.90%5.29B
20.34%5.07B
22.84%5.06B
20.93%4.66B
17.61%16.75B
22.44%4.56B
19.34%4.21B
14.48%4.12B
13.78%3.86B
Operating revenue
19.87%20.07B
15.90%5.29B
20.34%5.07B
22.84%5.06B
20.93%4.66B
17.61%16.75B
22.44%4.56B
19.34%4.21B
14.48%4.12B
13.78%3.86B
Cost of revenue
18.34%6.22B
9.69%1.61B
16.08%1.52B
28.90%1.64B
20.18%1.45B
20.99%5.26B
27.81%1.47B
19.16%1.31B
20.04%1.27B
16.25%1.21B
Gross profit
20.57%13.85B
18.84%3.68B
22.26%3.54B
20.14%3.42B
21.27%3.21B
16.12%11.49B
20.05%3.1B
19.41%2.9B
12.12%2.85B
12.69%2.65B
Operating expense
16.42%9.88B
14.40%2.64B
14.36%2.49B
20.97%2.48B
16.33%2.27B
13.51%8.49B
17.54%2.31B
19.92%2.18B
5.99%2.05B
10.65%1.95B
Selling and administrative expenses
15.09%6.89B
13.77%1.83B
11.46%1.74B
18.67%1.72B
17.08%1.6B
15.30%5.98B
16.90%1.61B
25.76%1.56B
6.79%1.45B
12.26%1.36B
Research and development costs
27.06%2.05B
23.97%569M
26.29%514M
37.34%526M
21.04%443M
14.21%1.62B
26.45%459M
14.33%407M
6.69%383M
8.61%366M
Depreciation amortization depletion
4.79%897M
1.33%228M
9.76%225M
5.63%225M
2.34%219M
3.38%856M
8.17%225M
-1.44%205M
1.43%213M
5.42%214M
-Depreciation and amortization
4.79%897M
1.33%228M
9.76%225M
5.63%225M
2.34%219M
3.38%856M
8.17%225M
-1.44%205M
1.43%213M
5.42%214M
Other operating expenses
39.39%46M
-33.33%6M
140.00%12M
55.56%14M
40.00%14M
-28.26%33M
-18.18%9M
-54.55%5M
-25.00%9M
-9.09%10M
Operating profit
32.28%3.97B
31.77%1.04B
46.24%1.05B
18.02%943M
35.21%937M
24.20%3B
28.04%790M
17.90%718M
31.63%799M
18.87%693M
Net non-operating interest income expense
-61.62%-320M
-325.93%-61M
-10.13%-87M
-16.88%-90M
-18.84%-82M
18.52%-198M
162.79%27M
-19.70%-79M
-10.00%-77M
-6.15%-69M
Non-operating interest income
-72.90%29M
----
----
----
----
386.36%107M
----
----
----
----
Non-operating interest expense
14.43%349M
12.50%90M
10.13%87M
16.88%90M
18.84%82M
15.09%305M
23.08%80M
19.70%79M
10.00%77M
6.15%69M
Other net income (expense)
48.75%-267M
-22.17%-281M
-189.66%-26M
129.47%89M
-172.22%-49M
-177.13%-521M
-233.33%-230M
-56.72%29M
-174.55%-302M
76.00%-18M
Gain on sale of security
233.68%127M
----
----
----
----
5.00%-95M
----
----
----
----
Special income (charges)
9.57%-359M
-92.04%-217M
-120.00%-3M
55.56%-124M
25.00%-15M
-436.49%-397M
-242.42%-113M
-82.35%15M
-203.26%-279M
37.50%-20M
-Less：Restructuring and merger&acquisition
981.82%119M
666.67%23M
120.00%3M
2,500.00%78M
-25.00%15M
-91.34%11M
-90.91%3M
-155.56%-15M
-91.43%3M
-37.50%20M
-Less:Impairment of capital assets
-88.08%46M
--0
--0
-83.33%46M
----
565.52%386M
--110M
--0
384.21%276M
----
-Less:Other special charges
--194M
----
----
----
----
----
----
----
----
----
-Gain on sale of business
----
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-20.69%-35M
-768.18%-191M
-264.29%-23M
1,026.09%213M
-1,800.00%-34M
-107.14%-29M
-134.38%-22M
177.78%14M
-27.78%-23M
104.65%2M
Income before tax
48.33%3.39B
19.66%700M
40.36%939M
124.05%941M
32.40%805M
14.96%2.28B
15.84%585M
9.67%669M
-1.41%420M
36.94%608M
Income tax
13.07%493M
30.43%30M
-8.50%183M
48.98%146M
15.65%133M
10.94%436M
2,200.00%23M
90.48%200M
-37.18%98M
-12.21%115M
Net income
56.66%2.89B
19.22%670M
61.32%755M
146.89%795M
36.31%672M
15.95%1.85B
11.51%562M
-7.14%468M
19.26%322M
57.01%493M
Net income continuous Operations
56.66%2.89B
19.22%670M
61.19%756M
146.89%795M
36.31%672M
15.95%1.85B
11.51%562M
-7.13%469M
19.26%322M
57.51%493M
Minority interest income
25.00%-6M
50.00%-2M
0
0.00%-2M
-100.00%-2M
-700.00%-8M
-300.00%-4M
0
-2M
-1M
Net income attributable to the parent company
56.31%2.9B
18.73%672M
61.32%755M
145.99%797M
36.44%674M
16.38%1.85B
12.08%566M
-7.14%468M
20.00%324M
57.32%494M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
56.40%2.9B
18.94%672M
60.98%755M
145.99%797M
36.16%674M
18.03%1.85B
11.88%565M
-7.13%469M
24.14%324M
65.00%495M
Basic earnings per share
55.56%1.96
18.42%0.45
59.38%0.51
145.45%0.54
35.29%0.46
16.67%1.26
11.76%0.38
-5.88%0.32
22.22%0.22
61.90%0.34
Diluted earnings per share
55.20%1.94
18.42%0.45
59.38%0.51
140.91%0.53
36.36%0.45
16.82%1.25
11.76%0.38
-5.88%0.32
22.22%0.22
57.14%0.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 19.87%20.07B15.90%5.29B20.34%5.07B22.84%5.06B20.93%4.66B17.61%16.75B22.44%4.56B19.34%4.21B14.48%4.12B13.78%3.86B
Operating revenue 19.87%20.07B15.90%5.29B20.34%5.07B22.84%5.06B20.93%4.66B17.61%16.75B22.44%4.56B19.34%4.21B14.48%4.12B13.78%3.86B
Cost of revenue 18.34%6.22B9.69%1.61B16.08%1.52B28.90%1.64B20.18%1.45B20.99%5.26B27.81%1.47B19.16%1.31B20.04%1.27B16.25%1.21B
Gross profit 20.57%13.85B18.84%3.68B22.26%3.54B20.14%3.42B21.27%3.21B16.12%11.49B20.05%3.1B19.41%2.9B12.12%2.85B12.69%2.65B
Operating expense 16.42%9.88B14.40%2.64B14.36%2.49B20.97%2.48B16.33%2.27B13.51%8.49B17.54%2.31B19.92%2.18B5.99%2.05B10.65%1.95B
Selling and administrative expenses 15.09%6.89B13.77%1.83B11.46%1.74B18.67%1.72B17.08%1.6B15.30%5.98B16.90%1.61B25.76%1.56B6.79%1.45B12.26%1.36B
Research and development costs 27.06%2.05B23.97%569M26.29%514M37.34%526M21.04%443M14.21%1.62B26.45%459M14.33%407M6.69%383M8.61%366M
Depreciation amortization depletion 4.79%897M1.33%228M9.76%225M5.63%225M2.34%219M3.38%856M8.17%225M-1.44%205M1.43%213M5.42%214M
-Depreciation and amortization 4.79%897M1.33%228M9.76%225M5.63%225M2.34%219M3.38%856M8.17%225M-1.44%205M1.43%213M5.42%214M
Other operating expenses 39.39%46M-33.33%6M140.00%12M55.56%14M40.00%14M-28.26%33M-18.18%9M-54.55%5M-25.00%9M-9.09%10M
Operating profit 32.28%3.97B31.77%1.04B46.24%1.05B18.02%943M35.21%937M24.20%3B28.04%790M17.90%718M31.63%799M18.87%693M
Net non-operating interest income expense -61.62%-320M-325.93%-61M-10.13%-87M-16.88%-90M-18.84%-82M18.52%-198M162.79%27M-19.70%-79M-10.00%-77M-6.15%-69M
Non-operating interest income -72.90%29M----------------386.36%107M----------------
Non-operating interest expense 14.43%349M12.50%90M10.13%87M16.88%90M18.84%82M15.09%305M23.08%80M19.70%79M10.00%77M6.15%69M
Other net income (expense) 48.75%-267M-22.17%-281M-189.66%-26M129.47%89M-172.22%-49M-177.13%-521M-233.33%-230M-56.72%29M-174.55%-302M76.00%-18M
Gain on sale of security 233.68%127M----------------5.00%-95M----------------
Special income (charges) 9.57%-359M-92.04%-217M-120.00%-3M55.56%-124M25.00%-15M-436.49%-397M-242.42%-113M-82.35%15M-203.26%-279M37.50%-20M
-Less：Restructuring and merger&acquisition 981.82%119M666.67%23M120.00%3M2,500.00%78M-25.00%15M-91.34%11M-90.91%3M-155.56%-15M-91.43%3M-37.50%20M
-Less:Impairment of capital assets -88.08%46M--0--0-83.33%46M----565.52%386M--110M--0384.21%276M----
-Less:Other special charges --194M------------------------------------
-Gain on sale of business ----------------------0----------------
Other non- operating income (expenses) -20.69%-35M-768.18%-191M-264.29%-23M1,026.09%213M-1,800.00%-34M-107.14%-29M-134.38%-22M177.78%14M-27.78%-23M104.65%2M
Income before tax 48.33%3.39B19.66%700M40.36%939M124.05%941M32.40%805M14.96%2.28B15.84%585M9.67%669M-1.41%420M36.94%608M
Income tax 13.07%493M30.43%30M-8.50%183M48.98%146M15.65%133M10.94%436M2,200.00%23M90.48%200M-37.18%98M-12.21%115M
Net income 56.66%2.89B19.22%670M61.32%755M146.89%795M36.31%672M15.95%1.85B11.51%562M-7.14%468M19.26%322M57.01%493M
Net income continuous Operations 56.66%2.89B19.22%670M61.19%756M146.89%795M36.31%672M15.95%1.85B11.51%562M-7.13%469M19.26%322M57.51%493M
Minority interest income 25.00%-6M50.00%-2M00.00%-2M-100.00%-2M-700.00%-8M-300.00%-4M0-2M-1M
Net income attributable to the parent company 56.31%2.9B18.73%672M61.32%755M145.99%797M36.44%674M16.38%1.85B12.08%566M-7.14%468M20.00%324M57.32%494M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 56.40%2.9B18.94%672M60.98%755M145.99%797M36.16%674M18.03%1.85B11.88%565M-7.13%469M24.14%324M65.00%495M
Basic earnings per share 55.56%1.9618.42%0.4559.38%0.51145.45%0.5435.29%0.4616.67%1.2611.76%0.38-5.88%0.3222.22%0.2261.90%0.34
Diluted earnings per share 55.20%1.9418.42%0.4559.38%0.51140.91%0.5336.36%0.4516.82%1.2511.76%0.38-5.88%0.3222.22%0.2257.14%0.33
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, in accordance with the Lebanon ceasefire agreement, announced Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -